Epic Research is not viewable using Internet Explorer. Please try accessing it with an alternate browser.
Cosmos Study

LDL Reductions Following Weight Loss Are Blunted in Patients Who Regain the Weight

July 31, 2025
Dual-Team Study
Team A:Kersten Bartelt, RNEric Barkley 
Team B:Dave Little, MDEmily Higgs

Key Findings

  • Patients who sustained a ≥10% weight loss over 18 months had an average LDL reduction of 6.2 mg/dL, compared to 2.7 mg/dL among patients who had little to no weight change and 1.9 mg/dL among those who lost and then regained weight. 
  • LDL decrease of 10 mg/dL or more was achieved by 41% of the sustained-loss group, compared to 33% in the steady group and 34% in the regain group. 
  • LDL increases from baseline of ≥10 mg/dL were more common in the regain group (32%) than in the steady (29%) or loss (27%) groups, indicating that weight regain blunts and may reverse cholesterol benefits. 

Obesity is a major modifiable risk factor for cardiovascular disease, and weight loss is associated with improvements in cardiovascular health, including cholesterol levels.1 However, many patients experience weight cycling (substantial weight loss followed by regain), which might impact cardiovascular health.2 While previous research highlights the benefits of sustained weight loss, less is known about the lipid profiles of individuals who regain lost weight. 

To understand the effects of weight cycling, we studied 156,096 adult patients with an obese BMI who had at least three BMI measurements over an 18-month period that demonstrated specific patterns in weight change. Patients were categorized into three weight patterns: sustained loss (≥10% reduction that was not regained), steady (weight remained within ±2% of baseline throughout), and regain (initial ≥10% reduction followed by return near baseline). LDL values were compared from baseline result around the time of their first qualifying BMI to an LDL result around the third BMI measurement. Patients were matched based on age, sex, BMI classification, social vulnerability, comorbidities, and use of lipid-lowering medications. 

We found that the average change in LDL differed by weight pattern. Patients in the sustained loss group had the largest average reduction, with LDL levels decreasing by 6.2 mg/dL. This contrasts with only a 1.9 mg/dL reduction in the regain group, despite similar initial weight loss, suggesting that cholesterol benefits attenuate quickly when weight is regained. Patients who maintained steady weight experienced a modest average decline of 2.7 mg/dL. The average LDL for all groups decreased, including those with stable weight, which might reflect underlying characteristics of the study population, such as increased likelihood of lipid management among those with repeat LDL testing. However, even within this potentially health-engaged subgroup, the gradient of LDL improvement across weight patterns suggests that the observed differences remain clinically meaningful. 

Figure 1
Average LDL Difference by Weight Change Group
Average LDL Difference by Weight Change Group
Figure 1. The average LDL difference by weight change group. 

The distribution of LDL changes further contextualizes these average effects. Patients in the sustained loss group were more likely to experience large reductions in LDL, with a greater proportion achieving improvements of 10 mg/dL or more compared to the other groups: 41% of the loss group had LDL reductions of at least 10 mg/dL, compared to 33% in the steady group and 34% in the regain group. Patients in the regain group had a greater proportion experiencing LDL increases. Approximately 32% of regain patients had LDL increases of 10 mg/dL or more, compared to 29% of the steady group and 27% of the loss group. Previous research has shown that weight loss can lead to transient increases in LDL levels, which might be a factor contributing to the LDL increase among the sustained weight loss group.3,4 

Figure 2
LDL Difference Distribution by Weight Change Group
LDL Difference Distribution by Weight Change Group
Figure 2. The distribution of LDL difference by weight change group.

These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 300 million patient records from 1,700 hospitals and more than 40,000 clinics from all 50 U.S. states, Lebanon, and Saudi Arabia. This study was completed by two teams that worked independently, each composed of a clinician and research scientists. The two teams came to similar conclusions. Graphics by Brian Olson. 

References

  1. Bays HE, Kirkpatrick CF, Maki KC, et al. Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. J Clin Lipidol. 2024;18(3):e320-e350. doi:10.1016/j.jacl.2024.04.001 
  2. Kakinami L, Knäuper B, Brunet J. Weight cycling is associated with adverse cardiometabolic markers in a cross-sectional representative US sample. J Epidemiol Community Health. 2020;74(8):662-667. doi:10.1136/jech-2019-213419 
  3. Surampudi, V., Biggs, K., & Li, Z. (2019). Weight loss and transient LDL increase (P12-057-19). Current Developments in Nutrition, 3(Suppl 1), nzz035.P12-057-19. https://doi.org/10.1093/cdn/nzz035.P12-057-19 
  4. Phinney, S. D., Tang, A. B., Waggoner, C. R., Tezanos-Pinto, R. G., & Davis, P. A. (1991). The transient hypercholesterolemia of major weight loss. The American Journal of Clinical Nutrition, 53(6), 1404–1410. https://doi.org/10.1093/ajcn/53.6.1404 

Data Definitions

Study period
Study population
Exposures
Outcomes
Matching factors
LDL
Amputation
Noninfective enteritis or colitis
Medications with weight-related side effects
Weight-related conditions
Lipid-lowering medication
Social Vulnerability Index